Potential additional revenue if FDA approval and a CPT code can be obtained for BMC using BIS or the existing CPT BIS code can be increased to cover this indication.
The last time we were updated in March 2022, 3 axing's ago. BIS is compared to DXA.
Below is from the last presentation.
CPT cost code for DXA currently US$52 per study.
There is a better way.
Acclivity
Potential additional revenue if FDA approval and a CPT code can...
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.4¢ |
Change
0.004(5.00%) |
Mkt cap ! $169.9M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.4¢ | 8.0¢ | $256.5K | 3.159M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.5¢ | 121194 | 2 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.3¢ |
Change
0.004 ( 3.75 %) |
||||
| Open | High | Low | Volume | ||
| 8.2¢ | 8.4¢ | 7.9¢ | 1002631 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| IPD (ASX) Chart |